Evidence map›Paper›PMID 38913938›Full record

Observational studyFuture microbiology2024

Theodoros Karampatakis, Eleni Kandilioti, Helen Katsifa, Anna Nikopoulou, Celine Harmanus, Katerina Tsergouli, Ed Kuijper, Melina Kachrimanidou

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Influence of COVID-19 on Clinical Outcomes ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Observational
  3. Article
  4. Insights into the Interaction BetweenJournal of personalized medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Theodoros KarampatakisMicrobiology Department, Papanikolaou General Hospital, 570 10, Thessaloniki, Greece.ORCID 0000-0003-0928-3193
Eleni KandiliotiMicrobiology Department, Papanikolaou General Hospital, 570 10, Thessaloniki, Greece.
Helen KatsifaMicrobiology Department, Papanikolaou General Hospital, 570 10, Thessaloniki, Greece.
Anna NikopoulouInfectious Disease Unit, Papanikolaou General Hospital, 570 10, Thessaloniki, Greece.
Celine HarmanusDepartment of Medical Microbiology, Center of Infectious Diseases, Leiden University Medical Center, European Study Group of C. difficile (ESGCD), 2333ZA, Leiden, The Netherlands.
Katerina TsergouliMicrobiology Department, Agios Pavlos General Hospital, 551 34, Thessaloniki, Greece.
Ed KuijperDepartment of Medical Microbiology, Center of Infectious Diseases, Leiden University Medical Center, European Study Group of C. difficile (ESGCD), 2333ZA, Leiden, The Netherlands.
Melina KachrimanidouDepartment of Microbiology, Aristotle University of Thessaloniki, Medical School, 541 24, Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridioides difficileClostridium InfectionsCOVID-19AdultAgedAged, 80 and overBacterial ProteinsBacterial ToxinsEnterotoxinsFecesFemaleGreeceHumansIncidenceMaleMiddle AgedBacterial ProteinsBacterial ToxinsEnterotoxinsClostridioides difficile infectioncoronavirus disease 2019 pandemicPCR ribotypingSARS-CoV-2toxin genes profile

Identifiers

PMID38913938
PMCPMC11529203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.